GlassScriptPhysician profile
Nso Agbor Nso
NPI 1750898367
$8,476.14
in general payments reported to CMS, 2019-2025
19 companies · $5,324 in 2025
The $5,324 reported for 2025 was more than what 99% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $150 · 2023: $565 · 2024: $2,437 · 2025: $5,324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $4,000 · Food and Beverage: $2,599 · Travel and Lodging: $1,409 · Education: $318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $4,000.00 |
| Food and Beverage | $2,598.82 |
| Travel and Lodging | $1,409.45 |
| Education | $318.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,359.21 | 2023-2025 | Resolute Onyx, Vitalflow Console, Corevalve Evolut R |
| Penumbra, INC. | $1,974.44 | 2024-2025 | Indigo System, Ruby Coil |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $551.05 | 2022-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $336.97 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $291.95 | 2023-2025 | Jardiance |
| Cook Medical LLC | $201.18 | 2024 | Cook |
| Abiomed | $149.70 | 2025 | |
| Shockwave Medical, INC | $136.79 | 2025 | |
| Pfizer INC. | $88.13 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $87.17 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $60.89 | 2023-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $53.79 | 2022-2024 | Xarelto |
| Edwards Lifesciences Corporation | $46.91 | 2022-2023 | Pascal |
| Abbott Laboratories | $37.79 | 2023-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Alnylam Pharmaceuticals INC. | $23.27 | 2025 | Onpattro |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $22.20 | 2024 | Repatha |
| Boston Scientific Corporation | $19.91 | 2025 | Avvigo Guidance System |
| Astrazeneca Pharmaceuticals LP | $19.20 | 2024 | Farxiga |
| Biosense Webster, INC. | $15.59 | 2023 | Na, Soundstar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nso Nso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.